Adam Inglis
Corporate Officer/Principal bei Beacon Health Options, Inc.
Profil
Adam Inglis is currently working as an Associate Vice President-Corporate Strategy at Beacon Health Options, Inc. Prior to this, he worked as a Vice President-Client Management at Provant Health Solutions LLC from 2013 to 2018.
He also served as an Independent Director at Xynomic Pharmaceuticals Holdings, Inc. Mr. Inglis completed his undergraduate degree from Hobart & William Smith Colleges in 2001.
Aktive Positionen von Adam Inglis
| Unternehmen | Position | Beginn |
|---|---|---|
Beacon Health Options, Inc.
 Beacon Health Options, Inc. Hospital/Nursing ManagementHealth Services Beacon Health Options, Inc. provides behavioral health solutions. It offers its services to large regional and specialty health plans, employers and labor organizations of all sizes, as well as federal, state and local governments. The company was founded in 2014 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01.11.2018 |
Ehemalige bekannte Positionen von Adam Inglis
| Unternehmen | Position | Ende |
|---|---|---|
Provant Health Solutions LLC
 Provant Health Solutions LLC Miscellaneous Commercial ServicesCommercial Services Provant Health Solutions LLC provides remote and onsite workplace wellness solutions for employees. The firm offers biometric screenings, health assessment, seasonal flu clinic, health coaching, advocacy, lifestyle management, and incentive program management services. The company was founded in 2001 and is headquartered in East Greenwich, RI. | Corporate Officer/Principal | 01.11.2018 |
| XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Adam Inglis
| Hobart & William Smith Colleges | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Xynomic Pharmaceuticals Holdings, Inc.
 Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Xynomic Pharmaceuticals Holdings, Inc. is a clinical stage best-in-class oncology therapeutics biopharmaceutical company. It engages in licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma and non-Hodgkin's lymphoma. The company was founded by Yinglin Mark Xu on October 7, 2016 and is headquartered in Shanghai, China. | Health Technology |
Beacon Health Options, Inc.
Beacon Health Options, Inc. Hospital/Nursing ManagementHealth Services Beacon Health Options, Inc. provides behavioral health solutions. It offers its services to large regional and specialty health plans, employers and labor organizations of all sizes, as well as federal, state and local governments. The company was founded in 2014 and is headquartered in Boston, MA. | Health Services |
Provant Health Solutions LLC
Provant Health Solutions LLC Miscellaneous Commercial ServicesCommercial Services Provant Health Solutions LLC provides remote and onsite workplace wellness solutions for employees. The firm offers biometric screenings, health assessment, seasonal flu clinic, health coaching, advocacy, lifestyle management, and incentive program management services. The company was founded in 2001 and is headquartered in East Greenwich, RI. | Commercial Services |
